Day 1: Monday October 4, 2010
|
| 7:00 |
Registration Opens |
| 8:00 |
Welcome Overview |
| 8:30 |
Keynote Address
8:30-9:00
Speaker:
- Carl Levin, United States Senator, Michigan, USA |
| 9:00 |
Keynote Address
9:00-9:30
Speaker:
- Jennifer Granholm, Governor, State of Michigan, USA |
| 9:30 |
Plenary Discussion
“The Immortal Life of Henrietta Lacks”—Lessons for Stem Cell Researchers and Patients
9:30-10:30
Moderator:
- Edward Goldman, University of Michigan School of Public Health, USA
Speakers:
- Jeremy Sugarman, Johns Hopkins University, USA
- Laurie Zoloth, Northwestern University, Feinberg School of Medicine, USA
- Chris Hempel, Addi & Cassi Fund, USA |
| 10:30 |
Break |
| 11:00 |
Science Keynote Address
11:00-11:30
Speaker:
- Sean Morrison, University of Michigan Center for Stem Cell Biology, USA |
| 11:30 |
KEYNOTE PRESENTATIONS
Keynote Presentation
11:30-12:00
TBA
Keynote Presentation
12:00-12:30
- A. Alfred Taubman, Founder and Chair, A. Alfred Taubman Medical Research Institute, USA
- Eva Feldman, University of Michigan Health System, USA
Keynote Address
12:30-1:00
TBA |
| 1:00 |
Expert Luncheons
1:00-2:30
(Exhibit Hall Opens) |
| 2:30 |
Focus Sessions:
Tissue Specific Stem Cell Research and Application I
2:30-3:30 - Science Track
Speakers:
- Yukiko Yamashita, University of Michigan, USA
- Sally Temple, Neural Stem Cell Institute, USA
- Anthony Hollander, University of Bristol, UK
Stem Cell Progress Report—Diabetes
2:30-3:30 - Society Track
Moderator:
- Juan Dominguez-Bendala, Diabetes Research Institute, USA
Effective Tools for Public Education Presented by Michigan Citizens for Stem Cell Research & Cures
2:30-3:30 - Society Track
Moderator:
- Sheri Mark, Michigan Citizens for Stem Cell Research & Cures, USA
Speakers:
- Danny Heumann, Heumannly Capable, USA
- Laura Jackson, Patient and Advocate, USA
- Marilyn Hysen, Michigan Citizens for Stem Cell Research & Cures, USA
Embryonic Stem Cell Research Oversight Committee (ESCRO) Workshop
2:30-3:30 - Society Track
Moderator:
- James Shayman, University of Michigan, USA
Speakers:
- Melinda Abelman, Partners HealthCare System, USA
- Lance Gable, Wayne State University, USA
- Lois Brako, University of Michigan, USA
The Outlook for the Cord Blood, Cell Therapy and Bio Banking Industries
2:30-3:30 - Industry Track
Moderator:
Sumi Dinda, Oakland University, USA
Speakers:
- William Prather, Pluristem Therapeutics, Inc.
- Thomas Klein, Cytolon AG, USA
- George Wilson, Beaumont Hospitals, USA
Devices and Tools for Research and Industry
2:30-3:30 - Industry Track
Speakers:
- Keith Murphy, Organovo, USA
- Representative from Beckman Coulter
- Kristi A. Hohenstein Elliot, Cyntellect, USA
Regenerative Medicine Against Aging—Technological, Political and Commercial Obstacles and Opportunities
2:30-3:30 - Society Track
Moderator:
- Aubrey de Grey, SENS Foundation, USA
Speakers:
- Dan Perry, Alliance for Aging Research, USA
- Michael West, BioTime, Inc., USA
- Huber Warner, University of Minnesota, USA
Financing Pathways for Cell Based Therapies
2:30-3:30 - Industry Track
Speakers:
- Robin Smith, Neostem Inc., USA
- Denis O'Donnell, Seaside 88 Advisors, USA
- Jason Kolbert, National Securities, USA
|
| 3:45 |
Concurrent Sessions:
Cellular Reprogramming Science Presentations
3:45-5:00 - Science Track
Moderator:
- Graham Parker, WSU School of Medicine, USA
Speakers:
- Carol Brenner, Wayne State University, USA
- M. William Lensch, Harvard Stem Cell Institute, USA
Michigan's Role in Stem Cell Research and as a Center for Regenerative Medicine Commercialization
3:45-5:00 - Industry Track
Moderator:
- Steve Rapundalo, MichBio, USA
Speakers:
- James Eliason, TechTown, USA
- Jeff Mason, Michigan's University Research Corridor, USA
- Timothy Mayleben, Aastrom Biosciences, USA
The NIH Guidelines and Sherley v. Sebelius - Implications for the Future of Stem Cell Research
3:45-5:00 - Society Track
Moderator:
- Alan Jakimo, Sidley Austin, USA
Speakers:
- Rosario Isasi, McGill University, Canada
- Karen Rothenberg, University of Maryland School of Law, USA
- Story Landis, National Institutes of Health (NIH), USA
A Consumer Guide—Clinical Uses of Stem Cells Derived from Cord Blood
3:45-5:00 - Society Track
Moderator:
- Rasul Chaudhry, Oakland University, USA
Speakers:
- John Wagner, University of Minnesota, USA
- Rita Perlingeiro, University of Minnesota, USA
- Wise Young, Rutgers University, USA |
| 5:00 |
Networking Reception in Exhibit Hall
5:00-7:00 |
Day 2: Tuesday October 5, 2010
|
| 8:00 |
Registration Opens |
| 8:00 |
Networking Breakfast |
| 9:00 |
Keynote Address
9:00-9:30
Speaker:
- Robert Klein, Chairman, Independent Citizens’ Oversight Committee, California Institute for Regenerative Medicine, USA |
| 9:30 |
Plenary Discussion
The California Model for Funding, Regulation and Successful Collaborations
9:30-10:30
Speakers:
- Robert Klein, California Institute for Regenerative Medicine, USA
- Nancy Koch, California Institute for Regenerative Medicine, USA
- Tak Mak, Ontario Cancer Institute, Canada
|
| 10:30 |
Break
|
| 11:00 |
Industry Keynote Address
11:00-11:30
Speaker:
- Thomas Okarma, President, Chief Executive Officer and Director, Geron Corp., USA |
| 11:30 |
Plenary Discussion
Current and Future Clinical Trials and Stem Cell Therapies
11:30-1:00
Moderator:
Eva Feldman, University of Michigan Health System, USA
Speakers:
- John Glass, Emory University School of Medicine, USA
- Richard Garr, Neuralstem, Inc., USA
- Nicholas Boulis, The Emory Clinic, USA |
| 1:00 |
Expert Luncheons
1:00-2:30
(Exhibit Hall Opens) |
| 2:30 |
Focus Sessions:
Disease Modeling Science Presentations
2:30-3:30 - Science Track
Moderator:
- Jack Parent, University of Michigan Medical Center, USA
Speakers:
- Gary Dunbar, Central Michigan University, USA
- Dan Kaufman, University of Minnesota, USA
Stem Cell Progress Report - ALS, Parkinson’s and other Neurological Diseases
2:30-3:30 - Society Track
Speakers:
- Timothy Collier, Michigan State University, USA
- John Yu, Cedars-Sinai Medical Center, USA
- Kathleen Russell, Parkinson's Action Network, USA
Sustaining the Mandate for Cures - Critical Lessons from Battleground States
2:30-3:30 - Society Track
Speakers:
- Donn Rubin, Missouri Coalition for Lifesaving Cures, USA
- Don Reed, Americans for Cures Foundation, USA
- John Schwarz, CureMichigan, USA
Stem Cell Standardization Issues
2:30-3:30 - Industry Track
Moderator:
- Doug Doerfler, MaxCyte, USA
Speakers:
- Anne Plant, National Institutes of Standards and Technology, USA
- David Smith, Lonza Walkersville, Inc., USA
- Brenton McCright, Food and Drug Administration, USA
- Rob Herrera, Cell Line Genetics, USA
Tech Transfer Roundtable
2:30-3:30 - Industry Track
Speakers:
- Robin Rasor, University of Michigan, USA
- Debra Grega, University of Michigan Medical School, USA
- Mark Rohrbaugh, National Institutes of Health (NIH), USA
Reimbursement and Insurance Solutions for Cell Therapies and Related Industries
2:30-3:30 - Industry Track
Moderator:
- Dawn Driscoll, DCi Biotech, USA
Speakers:
- James Walters, Aon Insurance, USA
Economic Development—Stem Cells and Regenerative Medicine as an Engine for Economic Growth
2:30-3:30 - Society Track
Moderator:
- Kurt Gunter, Hospira, Inc., USA
Speakers:
- Allen Goodman, Wayne State University, USA
- Chris Mason, University College London, United Kingdom
- Dan Gincel, Maryland Stem Cell Research Fund, USA
Regenerative Medicine Under the Microscope—VC and Investor Perspectives
2:30-3:30 - Industry Track
Moderator:
- Jeffrey Karan, Woodside Capital Partners, USA
Speakers:
- Matthew Plunkett, iPierian Inc., USA
- Morrie Ruffin, Adjuvant Global Advisors, USA
|
| 3:45 |
Concurrent Sessions:
Cancer Stem Cells Science Presentations
3:45-5:00 - Science Track
Speakers:
- Pranela Rameshwar, New Jersey Medical School, USA
Pharma's Growing Investment in Regenerative Medicine
3:45-5:00 - Industry Track
Moderator:
- Frank Bonner, Stem Cells for Safer Medicines, United Kingdom
Speakers:
- Alain Vertes, Roche, Switzerland
- Joseph F. Amaral, Johnson & Johnson Corporation, USA
Finding Common Ground—The Emerging Alliance Between Advocates and Industry
3:45-5:00 - Society Track
Moderator:
Bernard Siegel, Genetics Policy Institute, USA
Speakers:
- Mary Woolley, Research!America, USA
- Michael Werner, Holland & Knight, USA
- Andrew McKee, Juvenile Diabetes Research Foundation International, Canada
Hospital Perspectives on Stem Cells and Regenerative Medicine
3:45-5:00 - Industry Track
Moderator:
- Mark Rosenblum, Henry Ford Health System EOM, USA
Speakers:
- David Felten, Beaumont Research Institute, USA
- John Yu, Cedars-Sinai Medical Center, USA
|
| 5:00 |
Networking Reception in Exhibit Hall
5:00-7:00 |
| 7:00 |
Stem Cell Action Awards Dinner
7:00-9:00 |
Day 3: Wednesday October 6, 2010
|
| 8:00 |
Registration Opens |
| 8:00 |
Networking Breakfast |
| 9:00 |
Plenary Discussion
Toward Global Harmonization—Perspectives from International Network Leaders
9:00-9:30
Moderator:
- Drew Lyall, Stem Cell Network, Canada
Speakers:
- Surapol Issaragrisil, Mahidol University, Thailand
- Rosario Isasi, McGill University, Canada
- Geoffrey Lomax, California Institute for Regenerative Medicine, USA |
| 9:30 |
Focus Sessions:
Tissue Specific Stem Cell Research and Application Science Presentations II
9:30-10:30 - Science Track
Moderator:
James Eliason, TechTown, USA
Speakers:
- Joshua Hare, University of Miami Miller School of Medicine, USA
- Tim Kamp, UW-Madison Medical School, USA
- Avi Treves, Sheba Medical Center Cancer Research Center, Israel
Stem Cell Progress Report—Blindness
9:30-10:30 - Society Track
Moderator:
- Jeff Stern, New York Neural Stem Cell Institute, USA
Speakers:
- Stephen Rose, Foundation Fighting Blindness, USA
- Thomas Reh, University of Washington, USA
The Shifting Landscape of Intellectual Property Law and Its Impact on the Future of Regenerative Medicine
9:30-10:30 - Industry Track
Moderator:
- Rebecca Eisenberg, University of Michigan Law School, USA
Speakers:
- Nicholas Zachariades, Novak Druce + Quigg LLP, USA
- Samuel S. Woodley, Fish and Richardson, USA
- Robin A. Chadwick, Schwegman Lundberg & Woessner, USA
Risks and Rip-Offs—Where to Draw the Line on Stem Cell Tourism
9:30-10:30 - Society Track
Moderator:
- Doug Sipp, RIKEN Center for Developmental Biology, Japan
Speakers:
- Heather Rooke, ISSCR, USA
- Stephen Byer, ALS Worldwide, USA
- David Gelber, 60 Minutes, USA
Forging Relationships between Industry and Regulators
9:30-10:30 - Industry Track
Moderator:
- Ed Field, Aldagen, Inc., USA
Speakers:
- Michael Werner, Holland & Knight, USA
- Kimberly Benton, Food and Drug Administration, USA
- Adelheid Schneider, Roche Diagnostics, Germany
Stem Cell Progress Report—Spinal Cord Injury, Paralysis and MS
9:30-10:30 - Society Track
Speakers:
- Ellen Cogen-Lipton, Michigan State Representative, House District 27, USA
- Evan Snyder, Sanford-Burnham Medical Research Institute, USA
Stem Cell Progress Report—Cancer
9:30-10:30 - Society Track
Speakers:
- Max Wicha, University of Michigan Comprehensive Cancer Center, USA
- Ram Mandalam, Cellerant Therapeutics Inc, USA
Stem Cell Education—Innovative Tools for Teachers and Students and Funding Opportunities
9:30-10:30 - Society Track
Speakers:
- L. Tony Beck, National Institutes of Health, USA
- Rupa Shevde, WiCell Research Institute, USA
|
| 10:30 |
Concurrent Sessions:
Pluripotency Science Presentations
10:30-11:30 - Science Track
Moderator:
- K. Sue O’Shea, University of Michigan, USA
Speakers:
- Jose Cibelli, Michigan State University, USA
- Paul de Sousa, University of Edinburgh, Scotland
Commercialization of Stem Cells and International Market Trends
10:30-11:30 - Industry Track
Moderator:
- William B. Adams, International Stem Cell Corporation, USA
Speakers:
- Rafi Hofstein, MaRS Innovation, Canada
- Linda Powers, Toucan Capital, USA
- Dean Tozer, Advanced BioHealing, Inc., USA
Countries Having the Competitive Edge I
10:30-11:30 - Society Track
Moderator:
- Timo Faltus, University of Leipzig, Germany
Speakers:
- Kevin Price, Scottish Stem Cell Network, UK
- Abner M. Mhashilkar, International Venture Consultant, India
Healing Our Wounded Warriors—Armed Forces Investment in Regenerative Medicine
3:45-5:00 - Society Track
Moderator:
- Stan Gerson, National Center for Regenerative Medicine, USA
Speakers:
- Arnold Caplan, Case Western Reserve University, USA
- LTC Brian D. Moore, Armed Forces Institute of Regenerative Medicine (AFIRM), USA
- Alan Harris, Neostem, USA
|
| 11:30 |
Lunch
11:30-1:00 |
| 1:00 |
Concurrent Sessions:
Tissue Engineering Science Presentations
1:00-2:30 - Science Track
Speakers:
- Raphael Gorodetsky, Hadassah-Hebrew University Medical Center, Israel
- Gary Smith, Assisted Reproductive Technologies Laboratories, USA
- Harald Ott, Massachusetts General Hospital Center for Regenerative Medicine, USA
Partnering and M&A: Inside Information from the Regen Dealmakers
1:00-2:30 - Industry Track
Speakers:
- Gil Van Bokkelen, Athersys, Inc., USA
- Robert Shaw, Millipore Corporation, USA
- Frank Gleeson, Fate Therapeutics, USA
Countries Having the Competitive Edge II
1:00-2:30 - Society Track
Moderator:
- Ben Sykes, UK National Stem Cell Network, United Kingdom
Speakers:
- Megan Munsie, Australian Stem Cell Centre, Australia
- Ira Herrmann, Stem Cell Network NRW, Germany
- Natividad Cuende, Andalusian Initiative for Advanced Therapies, Spain
Global Clinical Trials Update
1:00-2:30 - Industry Track
Moderator:
- Doug Sipp, RIKEN Center for Developmental Biology, Japan
Speakers:
- Jorge Moreno-Cuevas, ITESM Escuela de Salud y Biotechnología, Mexico
- Gordon Sherriff, Angel Biotechnology PLC, United Kingdom
- Robert Hariri, Celgene Cellular Therapeutics, USA
|
| 2:30 |
Break |
| 2:45 |
Keynote Address
The Future of Stem Cells and Regenerative Medicine
2:45-3:15
Speaker:
- William Haseltine, William A. Haseltine Foundation for Medical Sciences and the Arts, USA
|
| 3:15 |
Plenary Discussion:
Empowering the Stem Cell Advocacy Movement
3:15-4:15
Moderator:
- Bernard Siegel, Genetics Policy Institute, USA
Speakers:
- Danny Heumann, Heumannly Capable, USA
- Grant Albrecht, Communication Unlimited, USA
- Sabrina Cohen, Sabrina Cohen Foundation for Stem Cell Research, USA |
| 4:15 |
stem cell awareness day town hall meeting
Removing Roadblocks to Stem Cell Research - Sherley v. Sebelius and Beyond
4:15-5:30
|
| 5:30 |
Closing Remarks |
| *Dates and times subject to change |
